Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion type Assertion NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_head.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion description "[This study indicates that the FGFR3 urine assay, which was originally developed to monitor bladder cancer, is also a useful tool for diagnosing upper urinary tract cancer in a real-life setting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_provenance.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion evidence source_evidence_literature NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_provenance.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion SIO_000772 22873290 NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_provenance.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion wasDerivedFrom befree-2016 NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_provenance.
- NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_assertion wasGeneratedBy ECO_0000203 NP1003585.RA56iAkZFxTjRe2AtVDOJ4RfKcfPPPODboz7RgdApLp2U130_provenance.